New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...

Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...

Yale researchers are sifting through a mosaic of cells in a living animal — both normal cells and mutated cells — to better understand how cancer grabs a foothold. But they’re starting by studying ...

A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...

How would you summarize your study for a lay audience? Research on gastrointestinal diseases, especially cancer, has mainly looked at the epithelial cells, which line the surfaces of organs, are ...

Scientists have discovered a molecular switch that can reverse cancer—turning cancer cells back into their healthy counterparts. The revelation by researchers from the Korea Advanced Institute of ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

In breast cancer cells, the scientists found an abundant amount of glycolytic enzymes on the cells' membrane, and that the molecules moved in organized waves. In normal cells, the scientists observed ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from researchers at Sinai Health in Toronto reveals that the total time it takes ...

A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.